-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Kuraray (TSE:3405) Fully Priced On Earnings Or Still Worth A Look?

Simply Wall St·08/10/2026 14:36:22
Listen to the news

Kuraray earnings event and why it matters now

Kuraray (TSE:3405) has come into focus after its half year earnings to June 30, 2026, with sales of ¥431,035 million and net income of ¥14,230 million compared with the same period last year.

See our latest analysis for Kuraray.

The earnings release appears to have been a key catalyst for Kuraray, with a 30 day share price return of 13.88% and a year to date share price return of 20.04% pointing to building momentum. The 5 year total shareholder return of 119.30% highlights how longer term holders have been rewarded.

If this earnings move has you thinking more broadly about opportunities, it could be a good time to widen your search with 10 top founder-led companies

Bulls point to Kuraray’s recent earnings and share price strength. Bears argue the move already prices in the good news. The next step is to see which side the current valuation appears to support.

Price-to-earnings of 75.5x for Kuraray, is it justified?

On the latest numbers, Kuraray trades on a P/E of 75.5x, which looks rich when you set it against both peers and an indicated fair level for the stock.

The P/E ratio compares the current share price with earnings per share. For a diversified chemicals group like Kuraray, it reflects how much investors are willing to pay today for each unit of current earnings. A higher multiple often lines up with strong earnings expectations, but it can also mean the bar is set high.

Here the current P/E of 75.5x stands far above the peer average of 13.4x and the broader JP Chemicals industry average of 12.7x. It also sits well above the estimated fair P/E of 22.2x that our fair ratio work suggests the market could eventually gravitate towards if sentiment cools. Taken together, this points to the market assigning a much richer earnings multiple than both history and sector context would indicate.

Explore the SWS fair ratio for Kuraray

Result: Price-to-earnings of 75.5x (OVERVALUED)

However, Kuraray’s rich 75.5x P/E and the current discount to the analyst price target both leave limited room for disappointment if earnings momentum cools.

Find out about the key risks to this Kuraray narrative.

Another view on Kuraray using our DCF model

The high 75.5x P/E paints Kuraray as expensive, yet our DCF model points in the opposite direction. On these cash flow forecasts, the stock around ¥1,920 is trading about 52.5% below an estimated fair value of ¥4,038.38, which frames Kuraray as materially undervalued.

That gap between an expensive earnings multiple and a discounted cash flow valuation raises a key question for you as an investor: Is the market overpaying for current earnings or underpricing Kuraray’s future cash flows.

Look into how the SWS DCF model arrives at its fair value.

3405 Discounted Cash Flow as at Aug 2026
3405 Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kuraray for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 19 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Kuraray’s story right now might look either exciting or stretched, depending on which metric stands out most to you. It makes sense to move quickly and weigh both the concerns and the potential upside for yourself with 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond Kuraray?

If Kuraray has sharpened your focus, do not stop here. Broaden your watchlist now or risk missing other stocks that could better fit your goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.